CD69 and chronic myelogenous leukemia, BCR-ABL1 positive: Regarding the expression of these activation markers on the CD56dim NK cell subset, our results showed a decreased expression of these markers in elderly CML patients, as well as a decreased expression of CD69 and HLA-DR in middle-aged CML patients compared with age-matched healthy donors.